| Jannette Marie Figueroa-velez, MD | |
|
100 Paseo San Pablo, Edif Dr Arturo Cadilla Vinas Suite 104, Bayamon, PR 00960 | |
| (787) 269-2442 | |
| Not Available |
| Full Name | Jannette Marie Figueroa-velez |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 100 Paseo San Pablo, Bayamon, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003009127 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 16951 (Puerto Rico) | Primary |
| 207UN0902X | Nuclear Medicine - Nuclear Imaging & Therapy | 16951 (Puerto Rico) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Jannette Marie Figueroa-velez, MD 363 Camino De Las Trinitarias, Veredas, Gurabo, PR 00778 Ph: (787) 220-8238 | Jannette Marie Figueroa-velez, MD 100 Paseo San Pablo, Edif Dr Arturo Cadilla Vinas Suite 104, Bayamon, PR 00960 Ph: (787) 269-2442 |
News Archive
Flavor, safety and family attitude toward vaping are among the greatest factors influencing teenage perception of e-cigarettes, new University at Buffalo research finds.
Amarantus BioScience, Inc., a biotechnology company discovering and developing treatments for diseases associated with protein misfolding and apoptosis, today announced that it has licensed the LymPro Alzheimer's Disease Diagnostic Blood Test (LymPro) from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, Inc.
Cylene Pharmaceuticals announced today that it has initiated a Phase I clinical trial of its oral CK2 protein kinase inhibitor, CX-4945, in patients with advanced solid tumors, Castleman's disease, or multiple myeloma.
A new Behavior Pain Assessment Tool (BPAT) provides a simple way to evaluate pain in critically ill patients—including those who aren't able to communicate their pain verbally, reports a study in PAIN, the official publication of the International Association for the Study of Pain. The journal is published by Wolters Kluwer.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, announced today that, as part of its collaboration with miRagen Therapeutics, positive data were generated demonstrating that RXi's sd-rxRNA technology can be used, in vitro, to specifically enhance the activity of a microRNA of high interest to miRagen.
› Verified 2 days ago
Dr. Ana I Rivera De La Vega, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Paseo San Pablo, Edif. Dr. Arturo Cadilla, Suite 201, Bayamon, PR 00961 Phone: 787-778-8774 Fax: 787-269-6190 | |
Boris M Guzman-hernandez, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: Mq10 Plaza 37, Monte Claro, Bayamon, PR 00961 Phone: 787-245-8870 Fax: 787-858-0434 | |
Jose M Rodriguez Castro, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Edif Metromedical, A- 608, Bayamon, PR 00959 Phone: 787-395-7125 Fax: 787-395-7126 | |
Dalvert H Polanco, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Ave Laurel, Bayamon, PR 00956 Phone: 787-787-5151 | |
Dr. Isabel E Cestero, M. D. Internal Medicine Medicare: Medicare Enrolled Practice Location: Route #2 Km 11.7 Bayamon Medical Plaza, Suite 409-b, Bayamon, PR 00959 Phone: 787-786-0473 Fax: 787-786-9718 | |
Joham Senior Marino, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Piso 1 Suite 104a, Bayamon Medical Plaza, Bayamon, PR 00960 Phone: 787-798-9522 Fax: 787-798-9500 |